Sermorelin

Laboratory research material

Research Use OnlyNot for human or veterinary use

Sermorelin

$45.00

Sermorelin copies the active opening section of natural GHRH and signals pituitary model cells to release growth hormone. The resulting signal can then be followed through the connected GH and IGF-1 pathway.

SKU: N/A Category:

Research focus

  • Growth-hormone release
  • GHRH receptor signaling
  • Endocrine feedback models
Laboratory Research Disclaimer

All chemical compounds available on this portal are engineered strictly for in-vitro laboratory evaluation and scientific research purposes only. These products are definitively not intended for human therapeutic, clinical, diagnostic, or veterinary applications.

Order reviewConfirm item and optionSecure checkoutProtected payment flowCOA accessReview available documentation

Documentation status

No public lot-specific report is posted for this product or selected variation. Do not infer identity, purity, sterility, endotoxin status, potency, or suitability from another product's report.

What Is Sermorelin?

Sermorelin is a synthetic 29-amino-acid fragment corresponding to the biologically active N-terminal region of human growth-hormone-releasing hormone, commonly written as GHRH(1-29). It is used as a defined ligand in GHRH-receptor and pituitary signaling research.

Overview

In research models, sermorelin activates the GHRH receptor and allows laboratories to follow cAMP, calcium, growth-hormone release, receptor responsiveness, and downstream GH/IGF-1-axis markers. It is especially useful as a comparator for full-length GHRH and more stable GHRH analogues.

In plain language, sermorelin lets researchers study the smallest well-known portion of the natural GHRH message that can still switch on its receptor.

History

Work in the 1980s established that the first 29 residues of the 44-amino-acid human GHRH sequence retained receptor activity. That finding made GHRH(1-29) a compact reference material for studying which part of the native signal is required for pituitary response.

Research Findings

  • GHRH(1-29) can activate GHRH receptors in receptor-defined and pituitary-cell systems.
  • Receptor activation is commonly tracked through cAMP/PKA signaling, calcium movement, and growth-hormone release.
  • Shorter persistence than stabilized analogues makes sermorelin useful for time-course and degradation comparisons.
  • Downstream GH/IGF-1 readouts remain dependent on the model, sampling window, and intact feedback pathways.

Documentation

Available analytical reports apply only to the exact product, strength, and lot identified on each report. A report for one strength or lot must not be assumed to cover another. Contact Fit Club Elite before ordering when a project requires lot-specific documentation.

Use Restrictions

For Research Use Only. Not for human or veterinary use. Not a food, drug, cosmetic, dietary supplement, or household product. Fit Club Elite does not provide medical, dosing, mixing, reconstitution, administration, or end-use guidance. Purchasers are responsible for lawful handling, storage, and use in an appropriate research setting.

Size

10mg

Research context

Review sources and documents

Research area
Receptor-characterization and non-clinical endocrine models
Last updated
September 30, 2026

Use these links to review published research. A source is not a protocol, recommendation, or promise that a result will apply in a different research model.

Find sources on PubMedFind sources on Europe PMC

Starting references reviewed

For laboratory research only. Not for human or veterinary use. We do not provide medical, dosing, mixing, or administration instructions.

Shopping Cart